LifeMD Reports Q3 Earnings with EPS Beat but Revenue Miss and Lowered Guidance
LifeMD (LFMD) reported third-quarter financial results featuring a GAAP earnings per share of -$0.11, which exceeded analyst expectations by $0.03. However, the company's revenue for the quarter reached $44.6 million, representing a 25.9% year-over-year decline and falling short of consensus estimates by $4.25 million. Looking ahead to the fourth quarter of 2026, LifeMD issued conservative financial guidance, projecting revenue between $46 million and $49 million. This outlook is significantly lower than the market consensus estimate of approximately $61.49 million, suggesting potential headwinds for the company's near-term growth trajectory.
Topics: earnings beat financial guidance quarterly results revenue miss